Glycolic Acid

Manufacturer
SSG Ventures Inc
Effective date
2021-04-07
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:40:51

Label at a glance#

ProductGlycolic Acid
Active ingredientGLYCOLIC ACID
Label structure1 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GP30GP30

INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Glycolic Acid

OTC - PURPOSE SECTION

FOR SKIN PRONE TO BREAKOUTS
FOR AGING SKIN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

WARNINGS SECTION

CAUTION
For external use only. Avoid contact with eyes and\ mucous membranes. In case of contact with eyes, flush with water. Some users may experience mild skin irritation. If irritation or redness lingers after rinsing, discontinue use and seek medical attention. Use caution when applying a solution stronger than 10% below the neckline. Keep out of reach of children.

OTC - PURPOSE SECTION

FOR SKIN PRONE TO BREAKOUTS
FOR AGING SKIN

INSTRUCTIONS FOR USE SECTION

DIRECTIONS
Cleanse area to be exfoliated

Use sterile gauze to apply a thin layer of acid peel to the skin

Wait for 60 to 90 seconds (20 seconds for first use; 20 to 60 seconds on sensitive skin)

Rinse with cool water

Repeat weekly until desired results

Apply sunscreen to any exfoliated areas for extra protection

INACTIVE INGREDIENT SECTION

Hydroxyethyl Cellulose, Preserved Water

DOSAGE & ADMINISTRATION SECTION

Cleanse area to be exfoliated


Use sterile gauze to apply a thin layer of acid peel to the skin


Wait for 60 to 90 seconds (20 seconds for first use; 20 to 60 seconds on sensitive skin)


Rinse with cool water


Repeat weekly until desired results


Apply sunscreen to any exfoliated areas for extra protection

INDICATIONS & USAGE SECTION

FOR SKIN PRONE TO BREAKOUTS
FOR AGING SKIN

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81376-701-012023-01-30C16284748780-1f386c649-ea6d-0266-e053-dadaa90a7c1apari Glycolic Acid Peel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81376-701-01Glycolic Acid30 mL in 1 BOTTLE, DROPPERLIQUID302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81376-701GLYCOLIC ACID (PARI 30% GLYCOLIC ACID PEEL) LIQUID [SSG VENTURES INC]2Legacy NDC, 1 package rows20210617_b7115586-4a68-9e45-e053-2995a90abfb7.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81376-70181376-701-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
bf66ec76-e8fb-b7c3-e053-2995a90a0a42b7115586-4a68-9e45-e053-2995a90abfb72021-04-07WarningsExact identifier
spl id: bf66ec76-e8fb-b7c3-e053-2995a90a0a42
spl set id: b7115586-4a68-9e45-e053-2995a90abfb7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.